Literature DB >> 2576528

[Neuronal degeneration and glutamate].

T Kirino.   

Abstract

Pathological conditions which interfere with normal brain energy metabolism causes similar neuronal degeneration. Cerebral ischemia, hypoglycemia, and status epilepticus are well known examples of such disease processes. Recently, it has come to be realized that the similarity of the pattern of neuronal degeneration is probably due to the toxicity of a putative neurotransmitter glutamate. Ischemic hippocampal damage in rodents has been studied as a typical experimental model. Following brief ischemia, the rodent hippocampus recovers completely and then starts degenerating over a few days. The delayed neuronal death of the hippocampus could be accounted for by excitotoxic action of glutamate. There is a considerable body of evidence to support this hypothesis. Extracellular glutamate actually increases following brief ischemia. Preceding destruction of glutamatergic input to the hippocampal CA1 (deafferentation) partially prevents ischemic neuronal damage in CA1. Various drugs are reportedly effective in preventing ischemic CA1 damage and some of them have a property of glutamate antagonist. However, why glutamate brings about cell necrosis is still not fully understood. Further study of basic mechanism is awaited.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576528

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  The blood-brain barrier and glutamate.

Authors:  Richard A Hawkins
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

2.  The role of glutamate release on voltage-dependent anion channels (VDAC)-mediated apoptosis in an eleven vessel occlusion model in rats.

Authors:  Eunkuk Park; Gi-Ja Lee; Samjin Choi; Seok-Keun Choi; Su-Jin Chae; Sung-Wook Kang; Youngmi Kim Pak; Hun-Kuk Park
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.